» Articles » PMID: 35453573

Modulating the Antioxidant Response for Better Oxidative Stress-Inducing Therapies: How to Take Advantage of Two Sides of the Same Medal?

Overview
Journal Biomedicines
Date 2022 Apr 23
PMID 35453573
Authors
Affiliations
Soon will be listed here.
Abstract

Oxidative stress-inducing therapies are characterized as a specific treatment that involves the production of reactive oxygen and nitrogen species (RONS) by external or internal sources. To protect cells against oxidative stress, cells have evolved a strong antioxidant defense system to either prevent RONS formation or scavenge them. The maintenance of the redox balance ensures signal transduction, development, cell proliferation, regulation of the mechanisms of cell death, among others. Oxidative stress can beneficially be used to treat several diseases such as neurodegenerative disorders, heart disease, cancer, and other diseases by regulating the antioxidant system. Understanding the mechanisms of various endogenous antioxidant systems can increase the therapeutic efficacy of oxidative stress-based therapies, leading to clinical success in medical treatment. This review deals with the recent novel findings of various cellular endogenous antioxidant responses behind oxidative stress, highlighting their implication in various human diseases, such as ulcers, skin pathologies, oncology, and viral infections such as SARS-CoV-2.

Citing Articles

Recent Issues in the Development and Application of Targeted Therapies with Respect to Individual Animal Variability.

Kurhaluk N, Tkaczenko H Animals (Basel). 2025; 15(3).

PMID: 39943214 PMC: 11815764. DOI: 10.3390/ani15030444.


Retinal Inflammation and Reactive Müller Cells: Neurotrophins' Release and Neuroprotective Strategies.

Balzamino B, Cacciamani A, Dinice L, Cecere M, Pesci F, Ripandelli G Biology (Basel). 2025; 13(12.

PMID: 39765697 PMC: 11673524. DOI: 10.3390/biology13121030.


Exploration and validation of a novel reactive oxygen species-related signature for predicting the prognosis and chemotherapy response of patients with bladder cancer.

Li Y, Zhang L, Xu G, Chen J, Zhao K, Li M Front Immunol. 2025; 15:1493528.

PMID: 39749345 PMC: 11693660. DOI: 10.3389/fimmu.2024.1493528.


Silica nanoparticles (SiNPs) derived from melon seed husk ameliorate Ni/Al mixture-mediated cognitive impairment in rats.

Anyachor C, Orish C, Ezejiofor A, Cirovic A, Cirovic A, Dooka B J Med Life. 2024; 17(9):856-867.

PMID: 39628974 PMC: 11611061. DOI: 10.25122/jml-2024-0019.


Redox Imbalance and Antioxidant Defenses Dysfunction: Key Contributors to Early Aging in Childhood Cancer Survivors.

Cossu V, Bertola N, Fresia C, Sabatini F, Ravera S Antioxidants (Basel). 2024; 13(11).

PMID: 39594539 PMC: 11590913. DOI: 10.3390/antiox13111397.


References
1.
Ding S, Li M, Gong H, Zhu Q, Shi G, Zhu A . Sensitive and Selective Measurement of Hydroxyl Radicals at Subcellular Level with Tungsten Nanoelectrodes. Anal Chem. 2020; 92(3):2543-2549. DOI: 10.1021/acs.analchem.9b04139. View

2.
Kellner M, Noonepalle S, Lu Q, Srivastava A, Zemskov E, Black S . ROS Signaling in the Pathogenesis of Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (ARDS). Adv Exp Med Biol. 2017; 967:105-137. PMC: 7120947. DOI: 10.1007/978-3-319-63245-2_8. View

3.
Daeschlein G, Rutkowski R, Lutze S, von Podewils S, Sicher C, Wild T . Hyperspectral imaging: innovative diagnostics to visualize hemodynamic effects of cold plasma in wound therapy. Biomed Tech (Berl). 2018; 63(5):603-608. DOI: 10.1515/bmt-2017-0085. View

4.
Deshmukh P, Unni S, Krishnappa G, Padmanabhan B . The Keap1-Nrf2 pathway: promising therapeutic target to counteract ROS-mediated damage in cancers and neurodegenerative diseases. Biophys Rev. 2017; 9(1):41-56. PMC: 5425799. DOI: 10.1007/s12551-016-0244-4. View

5.
McCord J, Fridovich I . Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem. 1969; 244(22):6049-55. View